Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Nuclera Nucleics Limited
*MAILING ADDRESS
137 Cambridge Science Park, Milton Road
*CITY
Cambridge
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
England
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
CB40GD
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
APPLICANT ENTERED NO DATA
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
001
*IDENTIFICATION
Chemical preparations, reagents, enzymes, gene editing enzymes for use in synthesising DNA, RNA, oligonucleotides, genes and proteins for
scientific and industrial purposes; nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA, synthetic RNA, synthetic
genes, synthetic oligonucleotides and synthetic proteins for scientific and industrial purposes
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical and veterinary preparations, namely nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical
and veterinary purposes; biological, chemical and biochemical reagents, namely DNA and RNA products, proteins, gene editing enzymes for clinical or medical use; synthetic DNA, synthetic RNA,
synthetic genes, synthetic oligonucleotides, synthetic proteins for clinical or medical use; DNA and RNA products for medical use; therapeutic DNA and RNA products; vaccines
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
009
*IDENTIFICATION
Scientific apparatus and instruments for DNA, RNA, gene and protein synthesis; cartridges; semiconductors; semiconductor chips; microchips;
bio sensors; bio-chips; apparatus and instruments for amplifying DNA and RNA; apparatus and instruments for synthesising DNA and RNA; apparatus and instruments for processing DNA and RNA; computer
hardware, computer software, downloadable computer software, bioinformatics software for use in connection with the aforesaid apparatus and instruments; parts and fittings for all the aforesaid
goods.
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
010
*IDENTIFICATION
Apparatus and instruments for DNA, RNA, gene and protein synthesis for medical and veterinary purposes; parts and fittings for all the
aforesaid goods.
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME
Rebecca Liebowitz
ATTORNEY DOCKET NUMBER
60895-554803
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Venable LLP
STREET
P.O. Box 34385
CITY
Washington
STATE
District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
20043-9998
PHONE
202-344-4976
FAX
202-344-8300
EMAIL ADDRESS
trademarkdocket@venable.com
OTHER APPOINTED ATTORNEY
Andrew D. Price, Halle B. Markus, Steven B. Powell, Paula E. Hopkins, Sean T. Phelan, Kristen Ruisi, Catherine Mitros, Sharoni Finkelstein,
Sahar Ahmed, Stephanie Semler
DOMESTIC REPRESENTATIVE INFORMATION
NAME
Rebecca Liebowitz
FIRM NAME
Venable LLP
STREET
P.O. Box 34385
CITY
Washington
STATE
District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP CODE
20043-9998
PHONE
202-344-4976
FAX
202-344-8300
EMAIL ADDRESS
trademarkdocket@venable.com
CORRESPONDENCE INFORMATION
NAME
Rebecca Liebowitz
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
trademarkdocket@venable.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
rliebowitz@venable.com; cmitros@venable.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
4
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
1400
*TOTAL FEES PAID
1400
SIGNATURE INFORMATION
SIGNATURE
NOT PROVIDED
SIGNATORY'S NAME
NOT PROVIDED
SIGNATORY'S POSITION
NOT PROVIDED
DATE SIGNED
NOT PROVIDED
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97132863
Filing Date:11/18/2021
To the Commissioner for Trademarks:
MARK: EGENE (Standard Characters, see mark)
The literal element of the mark consists of EGENE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Nuclera Nucleics Limited, having an address of
137 Cambridge Science Park, Milton Road
Cambridge CB40GD
England
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 001: Chemical preparations, reagents, enzymes, gene editing enzymes for use in synthesising DNA, RNA, oligonucleotides, genes and proteins for scientific and industrial
purposes; nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA, synthetic RNA, synthetic genes, synthetic
oligonucleotides and synthetic proteins for scientific and industrial purposes
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on United Kingdom application number UK00003644568, filed 05/20/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
International Class 005: Pharmaceutical and veterinary preparations, namely nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes;
biological, chemical and biochemical reagents, namely DNA and RNA products, proteins, gene editing enzymes for clinical or medical use; synthetic DNA, synthetic RNA, synthetic genes, synthetic
oligonucleotides, synthetic proteins for clinical or medical use; DNA and RNA products for medical use; therapeutic DNA and RNA products; vaccines
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on United Kingdom application number UK00003644568, filed 05/20/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
International Class 009: Scientific apparatus and instruments for DNA, RNA, gene and protein synthesis; cartridges; semiconductors; semiconductor chips; microchips; bio sensors; bio-chips;
apparatus and instruments for amplifying DNA and RNA; apparatus and instruments for synthesising DNA and RNA; apparatus and instruments for processing DNA and RNA; computer hardware, computer
software, downloadable computer software, bioinformatics software for use in connection with the aforesaid apparatus and instruments; parts and fittings for all the aforesaid goods.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on United Kingdom application number UK00003644568, filed 05/20/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
International Class 010: Apparatus and instruments for DNA, RNA, gene and protein synthesis for medical and veterinary purposes; parts and fittings for all the aforesaid goods.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on United Kingdom application number UK00003644568, filed 05/20/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
The owner's/holder's proposed attorney information: Rebecca Liebowitz. Other appointed attorneys are Andrew D. Price, Halle B. Markus, Steven B. Powell, Paula E. Hopkins, Sean T. Phelan, Kristen
Ruisi, Catherine Mitros, Sharoni Finkelstein, Sahar Ahmed, Stephanie Semler. Rebecca Liebowitz of Venable LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and
the attorney(s) is located at
P.O. Box 34385
Washington, District of Columbia 20043-9998
United States
202-344-4976(phone)
202-344-8300(fax)
trademarkdocket@venable.com
The docket/reference number is 60895-554803.
Rebecca Liebowitz submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant hereby appoints Rebecca Liebowitz of Venable LLP
P.O. Box 34385
Washington District of Columbia 20043-9998
United States
202-344-4976(phone)
202-344-8300(fax)
trademarkdocket@venable.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).
Declaration
Declaration Signature
Signature: Not Provided Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Signatory's Phone Number: Not Provided
Payment Sale Number: 97132863
Payment Accounting Date: 11/18/2021
Serial Number: 97132863
Internet Transmission Date: Thu Nov 18 19:25:38 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-202111181925385
76076-97132863-78163abf539aeb3210841ae84
bdcdb822ca0dcc41c9a0a4b2797ed4e27d2943d-
CC-25370691-20211118174113027157